Instrument Inactif

Communiqués YM BioSciences Inc. NYSE

Actions

Cours en clôture NYSE Autres places de cotation
- ^USD	-

29/02/12	YM Biosciences : Raises US$80.5 Million from Public Offering	PU
24/02/12	YM Biosciences : Prices $70 Million Public Offering of Common Shares	PU
23/02/12	YM Biosciences : Announces Proposed Public Offering of Common Shares	PU
09/02/12	YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	PU
12/12/11	YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	PU
22/11/11	YM Biosciences : Comments on Unusual Market Activity	PU
11/11/11	YM Biosciences : Reports Operational and Financial Results for the First Quarter of Fiscal 2012	PU
07/11/11	YM Biosciences : to Report Updated Phase I/II Data for CYT387 at ASH 2011	PU
31/10/11	YM Biosciences : Nimotuzumab Results Reported at SIOP Conference	PU
28/09/11	YM Biosciences : Initiates Phase II BID Trial with CYT387 in Myelofibrosis	PU
23/09/11	YM Biosciences : CORRECTION FROM SOURCE: YM BioSciences Reports Fiscal 2011 Year End Operational and Financial Results	PU
02/06/11	YM BioSciences Inc. (USA) : Yellowhead Mining Inc. Announces Voting Results of 2011 Annual and Special Meeting	PU
01/06/11	YM BioSciences Inc. (USA) : Yellowhead Mining Inc. Appoints VP Environment, Community & First Nations Relations; Also Manager, Corporate Administration	PU
30/05/11	YM BioSciences Inc. (USA) : YM BioSciences Provides Update on the Development Program for Nimotuzumab	PU